- Additional and prolonged anticoagulation in patients with acute coronary syndrome? The ATLAS ACS 2-TIMI 51 trialAlexander, NiessnerHamdan Medical Journal, 2012, 5(2): 189.
- Performance of the Dual AntiPlatelet Therapy (DAPT) Score in the ADAPT-DES StudyBrener, Sorin; Kirtane, Ajay Jayant; Rinaldi, Michael; Witzenbichler, Bernhard; Neumann, Franz-Josef; Henry, Timothy; Cox, David; Duffy, Peter L.; Mazzaferri, Ernest, Jr.; Brodie, Bruce; Mehran, Roxana; McAndrew, Thomas; Stone, Gregg29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Denver, CO, 2017-10-29 To 2017-11-02.
- Risk assessment of premature discontinuation of dual antiplatelet therapy in patients undergoing vascular surgery after second generation DES implantationZurakowski, Aleksander; Kachel, Mateusz; Szykowski, Dariusz; Nowakowski, Przemek; Milewski, Krzysztof; Buszman, Piotr29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Denver, CO, 2017-10-29 To 2017-11-02.
会议论文
Long-term outcomes of triple antithrombotic therapy (TT) versus dual antiplatelet therapy (NoTT) after coronary stenting: up to 4-years of follow-up
6阅读
